
GELITA Targets Biomedical Market with Ultra-Pure Collagen Innovations
At BIO International 2026 in San Diego, collagen specialist GELITA is debuting a new ultra-low endotoxin gelatin grade, pushing the purity limits for sensitive biomedical applications. The company aims to provide researchers with a consistent, high-performance foundation for everything from vaccine stabilization to regenerative medicine and complex 3D bioprinting.
























